TONI, Giulia
 Distribuzione geografica
Continente #
EU - Europa 15.174
NA - Nord America 5.418
AS - Asia 3.325
SA - Sud America 515
AF - Africa 82
OC - Oceania 19
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 24.537
Nazione #
IT - Italia 12.637
US - Stati Uniti d'America 5.275
SG - Singapore 1.194
CN - Cina 833
NL - Olanda 524
DE - Germania 469
BR - Brasile 410
FR - Francia 359
VN - Vietnam 355
UA - Ucraina 323
HK - Hong Kong 253
TR - Turchia 214
GB - Regno Unito 180
FI - Finlandia 167
IN - India 103
RU - Federazione Russa 92
JP - Giappone 78
SE - Svezia 70
CH - Svizzera 69
CA - Canada 63
MX - Messico 60
ES - Italia 52
PL - Polonia 51
ID - Indonesia 45
BD - Bangladesh 44
AR - Argentina 35
BE - Belgio 26
IQ - Iraq 24
TH - Thailandia 21
RO - Romania 19
ZA - Sudafrica 19
AU - Australia 17
CO - Colombia 16
EC - Ecuador 15
MY - Malesia 15
AT - Austria 14
DK - Danimarca 14
IR - Iran 14
KR - Corea 14
LT - Lituania 14
MA - Marocco 14
PH - Filippine 14
CZ - Repubblica Ceca 13
IE - Irlanda 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
IL - Israele 12
PK - Pakistan 12
SA - Arabia Saudita 12
GR - Grecia 11
BO - Bolivia 8
TW - Taiwan 8
VE - Venezuela 8
AL - Albania 7
KE - Kenya 7
TN - Tunisia 7
DZ - Algeria 6
EG - Egitto 6
JO - Giordania 6
MT - Malta 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
LB - Libano 5
AZ - Azerbaigian 4
BY - Bielorussia 4
OM - Oman 4
PE - Perù 4
UY - Uruguay 4
AO - Angola 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
HR - Croazia 3
JM - Giamaica 3
KZ - Kazakistan 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
SI - Slovenia 3
SM - San Marino 3
AQ - Antartide 2
CY - Cipro 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
LY - Libia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BG - Bulgaria 1
Totale 24.516
Città #
Milan 1.047
Rome 772
Singapore 737
Ashburn 560
San Jose 415
Fairfield 372
Woodbridge 319
Beijing 294
Chandler 270
Jacksonville 262
Santa Clara 250
Dallas 247
Hong Kong 243
Naples 210
Houston 208
Turin 185
Bologna 175
Ann Arbor 163
Florence 159
Seattle 155
Munich 153
Wilmington 148
Cambridge 136
Bari 132
Palermo 128
Izmir 123
Ho Chi Minh City 113
Brescia 106
Hanoi 100
Helsinki 96
Ferrara 91
Nanjing 80
Catania 78
Genoa 78
Los Angeles 78
Verona 78
Tokyo 75
New York 68
Bremen 65
Padova 65
Princeton 63
Lauterbourg 60
Redwood City 60
Modena 58
Perugia 56
Parma 54
Cagliari 53
Dearborn 51
Bergamo 45
Boardman 45
Shanghai 45
The Dalles 39
Reggio Emilia 38
São Paulo 37
Pescara 35
Trento 35
Trieste 34
Venice 34
Monza 32
Chicago 31
Falkenstein 31
Salerno 31
Treviso 30
Mexico City 29
San Diego 29
Napoli 28
Orem 28
Pisa 28
Tianjin 27
London 26
Amsterdam 25
Council Bluffs 24
Lucca 24
Rimini 24
Mountain View 23
Warsaw 23
Nanchang 22
Taranto 22
Toronto 22
Bolzano 21
Chennai 21
Moscow 21
Shenyang 20
Torino 20
Jiaxing 19
Washington 19
Reggio Calabria 18
Vicenza 18
Cinisello Balsamo 17
Jakarta 17
Livorno 17
Manchester 17
Afragola 16
Ancona 16
Como 16
Haiphong 16
Meda 16
Montreal 16
Novara 16
Boston 15
Totale 10.807
Nome #
Ustioni da airbag: una problematica emergente 10.418
Maintenance therapy: A crucial strategy in acne treatment 1.518
Linfangioma circoscritto vulvare: quando le cose si complicano. 989
Cinquanta sfumature di blu. 585
Anti-infiammatori non steroidei nell’acne: quale razionale? 469
Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: Results from a comparative trial 393
Possibili marcatori di malattia e prognosi nel lichen sclerosus vulvare: il contributo dell’epigenetica. 386
Anatomia e fisiologia dell’unità pilo-sebacea 309
null 309
Effect of Corticosteroid Phobia on Treatment Adherence and Outcome in Women With Lichen Sclerosus: A Prospective Study 244
Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients. 225
Safe use of oral isotretinoin after pseudo-tumor cerebri due to minocycline. 213
Insect repellents and contact sensitization: An observational study 213
Dermoscopy of patch test reactions: study of applicability in differential diagnosis between allergic and irritant reactions 204
Side-effects of tango: Connubial contact dermatitis 204
Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature. 203
Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment 198
Avocado and soybean extracts as active principles in the treatment of mild-to-moderate vulvar lichen sclerosus: Results of efficacy and tolerability 194
Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera? 193
Combining topical tretinoin with mometasone furoate in the treatment of vulvar lichen sclerosus: Results of dermoscopic assessment 187
Adapalene 0.1% / benzoyl peroxide 2.5% gel fixed combination after oral isotretinoin: evaluation of acne recurrence incidence. 176
Hidradenitis Suppurativa: The Effect Of Combinated Treatment With Oral Clindamycin And Rifampicin 174
Efficacy and safety of a 12-month treatment with a combination of hydroxypinacolone retinoate and retinol glycospheres as maintenance therapy in acne patients after oral isotretinoin 174
Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate? 174
Acne e retinoidi: come e quando impiegarli. 172
Aromatherapy and occupational allergic contact dermatitis: Two further cases caused by lavender oil and other essential oils 172
Severe vulvovaginal allergic contact dermatitis due to clotrimazole contained in multiple topical products 172
An update on hidradenitis suppurativa treatment. 171
Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment? 164
Systemic allergic dermatitis due to gentamicin 163
Level of use and safety of botanical products for itching vulvar dermatoses. Are patch tests useful? 161
Cortisonici a confronto. 153
Consensus conference su isotretinoina orale. 151
Low-cumulative dose isotretinoin treatment in mild to moderate acne. 150
Cryogenic burn by cryolipolysis [Ustione a frigore da criolipolisi] 150
I corticosteroidi sistemici nell’acne: perché, quando, come. 149
null 149
Plasma cell vulvitis: further confirmation of the diagnostic utility of dermoscopy 148
Acne meccanica da tutore ortopedico. 147
What’s new in acne? New therapeutic approaches. 146
Bullous irritant contact dermatitis caused by an alcoholic extract from Juglans regia leaves 146
Patch test reactions through the lens of dermoscopy: Further insights, particularly on weak allergic reactions 145
La biopsia del corneo nello studio dei comedoni. 143
Prospective clinical and epidemiologic study of vulvar lichen sclerosus: analysis of prevalence and severity of clinical features, together with historical and demographic associations. 143
Mammary pigmented Paget's disease in a male: A diagnostic challenge 143
Proposal for post-acne scar management algorithm. 137
Cheiliti da contatto 133
Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study 132
Maintenance therapy in acne 126
What treatments are on the horizon for acne. 124
Effectiveness of silk fabric underwear as an adjuvant tool in the management of vulvar lichen simplex chronicus: results of a double-blind randomized controlled trial 123
Topical treatment of acne: immunomodulatory approaches. 122
Rosacea Fulminans. 122
It looks like acne, but… 120
null 112
Micosi profonda ed iperplasia pseudolinfomatosa. 112
Dermoscopy of vulvar multiple syringomas: a diagnostic aid for a rare entity 109
Umbilical nodules: Two cases of atypical cutaneous endometriosis 108
Hidradenitis suppurativa: medical and surgical therapy review. 107
Pioderma gangrenoso recidivante del volto trattato con dapsone. 107
Lichen sclerosus vulvare: caratteristiche clinico-epidemiologiche, fattori di rischio ed elementi prognostici in pazienti seguite c/o l’ambulatorio di patologia vulvare. 105
Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index 105
Radiation-induced angiosarcoma of the breast: an uncommon polymorphic disorder 103
When traditional Chinese medicine runs on WhatsApp® 100
Proposal of a self-assessment questionnaire for the diagnosis of sensitive skin 99
Successful treatment of ectropion induced by actinic keratoses with photodynamic therapy: Report of two cases 98
null 95
Paget mammario pigmentato 95
Topical Corticosteroid Phobia Among Women Affected With Vulvar Lichen Sclerosus: Results From a Cross-sectional Survey 94
Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: Results of a randomized trial 90
null 83
Dermoscopy in plasma cell balanitis: its usefulness in diagnosis and follow-up. 82
Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment 81
Onychomadesis following hand, foot, and mouth disease: a case report from Italy and review of the literature. 68
Real-World Safety of Oral Isotretinoin in Patients During Sunny Months: Retrospective Cohort Study 66
Totale 24.748
Categoria #
all - tutte 62.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 837
Totale 63.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021520 0 0 0 0 0 0 0 0 0 182 175 163
2021/20221.761 154 205 135 151 129 81 115 94 90 147 141 319
2022/20232.570 223 188 126 191 237 208 184 165 229 177 271 371
2023/20243.792 352 395 329 291 245 279 234 235 189 349 443 451
2024/20255.051 539 500 458 291 495 406 316 352 505 423 392 374
2025/20265.993 620 381 615 664 840 478 735 400 531 729 0 0
Totale 24.748